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Abstract Much evidence has accumulated to show that
cellular membranes such as the plasma membrane, contain
multiple “microdomains” of diVering lipid and protein
composition and function. These domains are sometimes
enriched in cholesterol and sphingolipids and are believed
to be important structures for the regulation of many bio-
logical and pathological processes. This review focuses on
the use of Xuorescent (Bodipy) labeled analogs of sphingo-
lipids and cholesterol to study such domains. We discuss
the similarities between the behavior of Bodipy-cholesterol
and natural cholesterol in artiWcial bilayers and in cultured
cells, and the use of Bodipy-sphingolipid analogs to
visualize membrane domains in living cells based on the
concentration-dependent monomer-excimer Xuorescence
properties of the Bodipy-Xuorophore. The use of Bodipy-D-
erythro-lactosylceramide is highlighted for detection of
domains on the plasma membrane and endosome mem-
branes, and the importance of the sphingolipid stereochem-
istry in modulating domain formation is discussed. Finally,
we suggest that Bodipy-sphingolipids may be useful in
future studies to examine the relationship between
membrane domains at the cell surface and domains
enriched in other lipids and proteins on the inner leaXet of
the plasma membrane.
Keywords Lipid rafts · Gangliosides · 
Glycosphingolipids · Golgi apparatus · Sterols
Introduction
Microdomains represent local regions of membranes that
have a diVerent overall composition from the bulk mem-
brane and are thought to act as organizing centers to
sequester particular lipids and proteins. Although debate
continues concerning various aspects of microdomains
(e.g., size, number, lifetime), the concept has generated
important new ideas about the roles of lipids and mem-
branes in cellular functions (Kirkham and Parton 2005; Li
et al.  2005; Rajendran and Simons 2005). Evidence for
microdomains in various cellular membranes that diVer in
their properties from those of the bulk lipid bilayer mem-
brane comes from multiple approaches including “deter-
gent insolubility” of membrane components, cross-linking
of membrane proteins and lipids, biophysical studies of
constrained lateral diVusion in membranes, various Xuores-
cence methods (e.g., Xuorescence energy transfer; Xuores-
cence correlation spectroscopy), atomic force microscopy,
and EM studies [for reviews, see (Anderson and Jacobson
2002; Edidin 2003; Lawrence et al. 2003; London and
Brown  2000; Marguet et al. 2006; Parton and Hancock
2004; Simons and Toomre 2000)]. One class of micro-
domains, sometimes referred to as “lipid rafts” (Pike 2006;
Simons and Ikonen 1997), are regions of the membrane
enriched in sphingolipids (SLs) and cholesterol (See
Sect. ”Labeling of microdomains in living cells”). In model
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membranes prepared with mixtures of phospholipids and
cholesterol, microdomains with a short-range order (liquid-
ordered or lo domains) have been observed by Xuorescence
imaging to coexist with a disordered liquid phase (ld).
These in vitro liquid-ordered domains have some properties
in common with cholesterol/SL-enriched microdomains
that exist in cell membranes in vivo. However, microdo-
mains of cell membranes are inWnitely more complex in
terms of lipid composition, the presence of proteins that
may modulate microdomain structure, and the likelihood
that multiple types of microdomains may be present in the
same membrane. An understanding of cholesterol-SL
microdomains remains a challenge, and progress in this
Weld is dependent on the development of spectroscopically
observable lipid analogs that faithfully reXect the properties
of their parent molecule. This review focuses on the use of
SL and cholesterol analogs labeled with the Bodipy Xuoro-
phore to study microdomains in cell membranes in the
membranes of living cells.
Bodipy-lipid analogs: chemistry; spectral and physical 
properties
Spectral Properties of Bodipy Xuorophores
The Xuorophore known as Bodipy [boron dipyrromethene
(4,4-diXuoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene);
see Fig. 1a] was originally used by us in studies of SL
synthesis and transport along the secretory pathway in
cultured mammalian cells (Pagano et al. 1991). It is now
called “Bodipy-FL” by Invitrogen but is referred to as
“Bodipy” throughout this review. Because of its unique
spectral properties and superior photo-stability compared to
other Xuorophores such as nitrobenz-2-oxa-1,3-diazol-4-yl
(NBD) and Xuorescein, we subsequently generated other
Bodipy-analogs for lipid traYcking studies. Lipid analogs
labeled with the Bodipy Xuorophore exhibit monomer/exci-
mer Xuorescence emission. Thus, when present in mem-
branes at relatively low concentrations and excited with
blue light (e.g., 470 nm) the probe emits at green wave-
lengths (peak at 515 nm); however, when the Xuorescent
probe is present at higher concentrations, the green emis-
sion is partially quenched and a second peak of Xuores-
cence is observed at red wavelengths (»620 nm). This
concentration-dependent spectral shift occurs in vitro [e.g.,
with Bodipy-ceramide (Cer) in liposomes; Fig. 1b] and in
living cells [e.g., using Bodipy-lactosylceramide (LacCer);
Fig. 1c], thus allowing one to distinguish regions of a mem-
brane that contain relatively high concentrations of the lipid
analog (and Xuorescent red) from other regions in which
the probe is present at lower concentrations that Xuorescent
green. Another example of this phenomenon is shown in
Fig. 1d in which Bodipy-Cer and its metabolites accumu-
late in the Golgi apparatus of human skin Wbroblasts. The
apparent molar density of the Bodipy-analog can be esti-
mated in the region of interest by quantifying the intensities
of the red and green emissions and comparing this to a cali-
bration curve relating red/green emission ratios to the molar
density of the Bodipy-lipid analog in liposomes imaged
under the same conditions as the cells (Chen et al. 1997;
Pagano et al. 1991).
A number of modiWcations to the Bodipy group have
been prepared by Invitrogen and others (Li and Bittman
2007; Qin et al. 2007). These substitutions to the Xuoro-
phore result in analogs with diVerent spectral properties. Of
these novel Xuorophores, only Bodipy-TR, which has Xuo-
rescence properties similar to Texas Red, has been used to
label SL analogs. Several studies have used Bodipy-TR-Cer
as a probe for the Golgi apparatus (Field et al. 2000; Gang-
alum et al. 2004).
Structures of SLs and analogs
Sphingolipids are a large class of lipids found in eukary-
otes as well as in some bacteria. In addition to their func-
tions within cholesterol-enriched microdomains, SLs play
important roles in cell signaling, cell–cell interactions,
and pathophysiological processes (Ariga et al. 2008; Han-
nun and Obeid 2008; Holland and Summers 2008; Regina
Todeschini and Hakomori 2008). In mammalian cells
there are hundreds of molecular species of SLs with
sometimes confusing trivial and systematic names [for
comprehesive reviews, see (Fahy et al. 2005; Hakomori
2003; Shayman and Radin 1991)]. However, the basic
structure of SLs can be considered to be a sphingosine
core (also known as the “long-chain base”), an amide-
linked fatty acid, and a polar head group (see Fig. 2a).
Cer, from which sphingomyelin (SM) and glyco-
sphingolipids (GSLs) are derived, lacks the phosphocho-
line and carbohydrate head group present in SM and
GSLs, respectively. Most cell types synthesize glucosyl-
ceramide (GlcCer), which consists of glucose in a -ano-
meric linkage with Cer. Other sugars are added to the
glucose head group to form higher-order GSLs (Fig. 2a).
For example, incorporation of galactose (Gal) into GlcCer
forms the disaccharyl-SL, LacCer (Fig. 2b). GSLs that
possess sialic acid residues are called gangliosides (e.g.,
see GM1 in Fig. 2a). In some tissues, -linked galacto-
syl-Cer (GalCer) is synthesized, which can be further
modiWed by a sulfate ester to form sulfatide (Fig. 2a).
DiVerences in fatty acid chain length, variation in saccha-
ride chains, and variations in sphingosine chain length
and structure (e.g., hydroxyl groups, double bonds)
account for the great numbers of individual SL molecular
species found (Bittman 2008).Histochem Cell Biol (2008) 130:819–832 821
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Unusual SLs
Carbons 2 and 3 of the sphingosine backbone are asymmet-
ric; thus, four potential stereoisomers of SLs can be envi-
sioned (see Fig. 2b for an example showing the
stereoisomers of LacCer). All natural mammalian SLs have
the D-erythro (or 2S,3R) stereochemistry. As noted below,
alterations in the stereochemistry of the long-chain base
drastically changes the biophysical and biological behavior
of LacCer. Interestingly, SLs with diVerent (L-threo or
2S,3S) stereochemistry occur in plants, marine inverte-
brates, and fungi (Emura et al. 2005; Gao et al. 2004; Ina-
gaki et al. 2006; Ishii et al. 2006; Ling et al. 2006; Oueslati
et al. 2005; Yamada et al. 2000; Zhang et al. 2007). While
all mammalian GSLs possess the -anomeric linkage
between the Wrst sugar and Cer, an unusual set of -linked
Fig. 1 Spectral characteristics 
of the Bodipy Xuorophore. a 
Chemical structure of the unsub-
stituted core of the Bodipy 
Xuorophore. b Fluorescence 
emission spectral of lipid vesi-
cles containing various amounts 
of Bodipy-C5-ceramide (Bo-
dipy-Cer). Small unilamellar 
vesicles were formed from 
POPC and 2, 5, 10, 20, and 
50 mol% Bodipy-Cer (total lipid 
content was 31 M). Excitation 
was at 480 nm. Inset: Ratio of 
relative Xuorescence intesities at 
620 and 515 nm vs mol % Cer. 
[Adapted from © Pagano et al. 
1991. Originally published in 
The Journal of Cell Biology 
113:1267–1279]. c Human skin 
Wbroblasts labeled for 30 min at 
10°C with 2.5 M Bodipy-C5-
lactosylceramide (Bodipy-Lac-
Cer) followed by 5 min at 37°C. 
Note the heterogeneous labeling 
of endocytic vesicles at red and 
green wavelengths, indicating 
respectively high and low con-
centrations of Bodipy-LacCer in 
the endosomal membranes. d) 
Human skin Wbroblasts labeled 
with Bodipy-Cer for 30 min at 
10°C. Note Golgi labeling in red 
and more diVuse labeling of 
intracellular membranes in 
green. For c and d, samples were 
excited with blue light (470 nm) 
and emission was visualized 
with green (540 nm) and red 
(¸590 nm) Wlters. Bar =1m822 Histochem Cell Biol (2008) 130:819–832
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Fig. 2 Structures of sphingolipids and Bodipy-cholesterol. a Model
showing component parts of sphingolipids; sphingosine core, head
groups, and fatty acid. In Bodipy-SLs the natural fatty acid is replaced
by a Bodipy fatty acid. R indicates head groups such as phosphocholine
in SM and saccharides found in GSLs. b Illustration of four stereoiso-
mers of LacCer indicating the asymmetric carbon atoms, C-2 and C-3.
c Structures of cholesterol and Bodipy-cholesterol
A
B
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GSLs from microbes and marine sponges have been found
to activate natural killer T cells. The reader is referred to
(Bittman 2008) for a discussion of these and other unusual
SLs.
Bodipy-SL analogs
We have prepared a variety of SL analogs in which the fatty
acid moiety is replaced by a Bodipy fatty acid. These
include Bodipy-Cer, -GlcCer, -GalCer, Maltosyl-Cer, -Lac-
Cer, -SM, -GM1, -GM3, and -sulfatide [see Fig. 2a and
(Martin and Pagano 1994; Pagano et al. 1991; Singh et al.
2003; Watanabe et al. 1999)]. Some of these compounds
are now available from Invitrogen. In most cases, the SL
analogs were generated using Bodipy-labeled pentanoic
acid (C5) as in Fig. 2a, although longer and shorter chain
length Bodipy-fatty acids are commercially available and
can be used, depending on the application. Unlike most
Xuorophores, Bodipy is relatively nonpolar and electrically
neutral. These features make it desirable for the synthesis
of SL probes since it replaces the natural fatty acid and, in
principle, is capable of intercalating into membrane
bilayers more readily than hydrophilic Xuorophores. For
example, in a comparison of the properties of Bodipy- vs
NBD-labeled Cer analogs, it was found that the Bodipy
Xuorophore appears to better intercalate into the membrane
bilayer than the NBD Xuorophore (Chattopadhyay and
London 1987; Kaiser and London 1998). A useful property
of Bodipy-SLs, which is also true of NBD-SLs, is that they
can be easily combined in a complex with defatted bovine
serum albumin (DF-BSA) to make a water-soluble delivery
system for transfer of the lipid analog to cells (Martin and
Pagano 1994). In addition, Bodipy-SLs in the outer leaXet
of the PM of cells can easily be removed by adding DF-
BSA to the medium in a process called “back exchange,”
thus allowing the visualization of Xuorescent lipid which
has been internalized by the cell without interference from
Xuorescent lipid remaining at the PM (Koval and Pagano
1989; Martin and Pagano 1987, 1994).
Cholesterol and Bodipy-cholesterol analogs
Cholesterol is a key lipid component of mammalian cell
membranes where it plays a unique role in determining
membrane properties [for recent reviews, see (Ikonen 2008;
MaxWeld and Tabas 2005; Schroeder et al. 2001; Simons
and Ehehalt 2002)]. For example, cholesterol aVects mem-
brane Xuidity, rigidity, and as mentioned above, the ability
of membranes to form laterally segregated microdomains.
To further understand cholesterol function and transport in
the living cell, Xuorescently labeled cholesterol analogs
would be very useful. An ideal cholesterol probe would
exhibit properties similar to those of cholesterol in the
highly packed and ordered environment typical of lipid
rafts, would not markedly perturb membrane structure, and
would possess photo-physical properties suitable for use in
live cell Xuorescence microscopy of cholesterol-rich mem-
brane domains. The development of such an analog has
been problematic, because the size, hydrophobicity, and the
site of attachment of the Xuorophore to the sterol molecule
all can aVect how the probe molecule is partitioned in mem-
brane domains. Several analogs of cholesterol were synthe-
sized in which Bodipy has been inserted into the aliphatic
tail of the free sterol. One compound, referred to here as
Bodipy-cholesterol (Fig. 2c) in which carbon-24 of choles-
terol is linked directly to a Bodipy moiety, exhibited similar
physical behavior to cholesterol (Li and Bittman 2007; Li
et al. 2006; Shaw et al. 2006). In particular, in model mem-
branes Bodipy-cholesterol partitioned into liquid-ordered
domains, as judged by (a) its distribution into a Triton X-
100 low-density insoluble fraction (a biochemical method
based on the resistance of lipid rafts to be extracted by a
detergent) and (b) atomic force microscopy-confocal Xuo-
rescence imaging data. Furthermore, the rate of desorption
of Bodipy-cholesterol from monolayers was similar to that
of cholesterol on addition of a water-soluble cyclodextrin
to mixed monolayers with SM. Bodipy-cholesterol also
preferentially partitioned into the lo phase of giant unila-
mellar vesicles, in contrast to the ld-domain speciWcity of
the Xuorescent probe 1,1-didodecyl-3,3,3,3-tetramethyl-
indocarbocyanine perchlorate (diI-C12) (Florly S. Ariola,
Robert Bittman, and Ahmed A. Heikal, unpublished obser-
vations). These data demonstrate the potential of this
analog for studying lipid–lipid interactions, lipid order, and
membrane Xuidity of biologically relevant lo domains.
Labeling of microdomains in living cells
DeWnitions of “microdomains”
The concept of lateral heterogeneity of biological mem-
branes has been discussed for over two decades. Much evi-
dence has been accumulated to show that membranes [e.g.,
the plasma membrane (PM)] consist of multiple domains
(or microdomains) of diVering lipid and protein composi-
tion and function (Mishra and Joshi 2007). In this review
we focus on SL- and cholesterol-enriched microdomains,
sometimes referred to as “rafts,” detergent-resistant mem-
branes, or GSL-enriched membranes. Even within this cate-
gory, it is expected that there exist multiple types of
microdomains with diVerent functions. For example, one
category of SL- and cholesterol-enriched microdomain is
caveolae,: Xask-shaped 50–100 nm invaginations of the PM
deWned by the presence of the caveolin protein (Jacobson
et al.  2007). Apparently distinct from caveolae are824 Histochem Cell Biol (2008) 130:819–832
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microdomains enriched in glycosylphosphatidyl-inositol
(GPI)-anchored proteins (Schnitzer et al. 1995). In a further
example of multiple microdomains within the same cell
type, Hakomori and colleagues used detergent insolubility
fractionation of B16 melanoma cells combined with
immuno-isolation to separate a GM3 ganglioside-enriched
fraction that also contained SM and RhoA from a caveolin-
enriched fraction that did not contain GM3 (Iwabuchi et al.
1998).
The size of putative microdomains has been explored,
and estimates from 5 nm to 1 m have been reported using
a variety of technologies (Harding and Hancock 2008; Jac-
obson et al. 2007). Current consensus is that microdomains
are typically smaller than 200–300 nm (Devaux and Morris
2004; Jacobson et al. 2007; Mishra and Joshi 2007), but
this size is too small to be visualized by conventional Xuo-
rescence microscopy. However, microdomains can be
induced to coalesce into larger structures by certain stimuli
(Harder and Engelhardt 2004; Kusumi and Suzuki 2005).
For example, cross-linking of the GPI-anchored protein
placental alkaline phosphatase with antibodies causes it to
move into patches which also contain GM1 ganglioside and
the src-like protein tyrosine kinase, fyn (Harder et al.
1998).
Cell fractionation studies
Bodipy-LacCer
Biochemical studies were performed to determine if
Bodipy-LacCer partitioned into cellular microdomains.
Bodipy-LacCer (5 M) was incubated with human skin
Wbroblasts for 30 min at 10°C. Cells were then washed and
then fractionated using the detergent-free method for isolat-
ing microdomains developed by Smart et al. (1995). In this
method, an Optiprep gradient is used to separate the buoy-
ant microdomain fraction from other membranes. As shown
in Fig. 3a, Cav1, a marker for microdomains, was dis-
tributed mainly near the top of the gradient. Clathrin heavy
chain (Fig. 3a) and the bulk of cell protein (not shown)
were distributed at the bottom of the gradient. Bodipy-Lac-
Cer was quantiWed in gradient fractions and found to occur
mainly in the upper fractions with Cav1 (Fig. 3b). Finally,
when non-Xuorescent C8-LacCer (which stimulates the
coalescence of microdomains; see below) was added to
cells with Bodipy-LacCer, an even greater portion of
Bodipy-LacCer was recovered in the Cav1-enriched frac-
tions. However, when Bodipy-LacCer was added after cells
were homogenized (post-lysis control), the Xuorescent
probe was distributed mainly in lower fractions (Fig. 3b).
This control shows that the distribution of Bodipy-LacCer
in the buoyant microdomain fractions occurs in the living
cells and is not due to the scrambling of the lipid after
homogenization. In contrast, when Bodipy-LacCer was
added to cells, and cells were subjected to cold 1% Triton
X-100 treatment and sucrose gradient fractionation,
Bodipy-LacCer was found associated with the Triton X-
100 soluble fraction and not with the insoluble fraction
(unpublished data). Thus, the ability of Bodipy-LacCer to
partition into domains in living cells does not correlate with
its Triton X-100 solubility.
Bodipy-cholesterol and radiolabeled cholesterol
Overnight incubation of Chinese hamster ovary (CHO)
cells with Bodipy-cholesterol in a medium containing
lipoprotein-deWcient serum resulted in bright labeling of
cells with a negligible (»1%) increase in total cellular
sterols. To compare the distribution of Bodipy-cholesterol
with radiolabeled cholesterol in subcellular membranes, the
cells were incubated overnight with both Bodipy-choles-
terol and [3H]cholesterol, and the membranes were frac-
tionated in the post-nuclear supernatant by sucrose density
gradient centrifugation. Bodipy-cholesterol partitioned into
cellular membranes with diVerent equilibrium densities
Fig. 3 Behavior of Bodipy-LacCer in cell fractionation studies. a, b
Human skin Wbroblasts were incubated with 5 M Bodipy-LacCer in
HMEM for 30 min at 10°C and then washed. Cells were then scraped
and fractionated by the detergent-free method of Smart et al (1995) to
recover buoyant membrane microdomains. Data shown are from the
last step of the fractionation using an Optiprep gradient. Western blot-
ting a shows that Cav1, a marker for microdomains, occurs in early,
buoyant fractions (1–3) whereas clathrin heavy chain as well as the
bulk of protein (not shown) occur in the later fractions (6–9). Equal
volumes were loaded for western blots. b The distribution of Bodipy-
LacCer was examined by lipid extraction, thin layer chromatography,
and image analysis, and shows that the Xuorescent lipid is distributed
mainly in the buoyant fractionsHistochem Cell Biol (2008) 130:819–832 825
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very similarly to [3H]cholesterol. To analyze if Bodipy-
cholesterol exhibits aYnity for DRMs, CHO cells labeled
with Bodipy- and radiolabeled cholesterol were lysed in
cold 1% Triton X-100, and the detergent-insoluble material
was pelleted. The results indicate that Bodipy-cholesterol
associated with DRMs to a similar extent as radiolabeled
cholesterol (Hölttä-Vuori et al. 2008).
Fluorescence microscopy studies
Visualization of PM microdomains 
with Bodipy-D-erythro-LacCer
Our initial studies using Bodipy-D-erythro-LacCer were
focused on its mechanism of endocytosis and subsequent
cellular itinerary (Choudhury et al. 2002a; Martin and Pag-
ano 1994; Puri et al. 1999; Puri et al. 2001; Sharma et al.
2003). We found that this lipid analog underwent endocyto-
sis selectively via caveolae in multiple cell types [for a
review of techniques to study mechanisms of endocytosis,
see (Marks et al. 2005; Singh et al. 2007b)]. In these stud-
ies, 1–2 M Bodipy-D-erythro-LacCer was typically incu-
bated with cells at 10°C to allow binding to the PM and
then warmed to 37°C to initiate endocytosis. When cells
were viewed after the low temperature binding step but
without warm up, Bodipy-D-erythro-LacCer exhibited a
relatively homogeneous distribution on the PM (see Fig. 4a,
top left panel). We subsequently noted that under certain
conditions, Bodipy-D-erythro-LacCer could be induced to
redistribute into non-homogeneous »1 m size patches
with increased red Xuorescence (indicating higher local
Xuorescent lipid concentrations) on the PM (Fig. 4a, middle
and right panels). These conditions included (1) co-incuba-
tion with 20 M non-Xuorescent C8-D-erythro-LacCer or
with natural chain length GSLs, (2) use of higher concen-
trations (2.5–10 M) of Bodipy-D-erythro-LacCer (see
Fig. 4a top middle and right panels), (3) co-incubation with
cross-linking  1-integrin antibody, and (4) co-incubation
with cholera toxin B subunit (CTxB), plus anti CTxB anti-
body (Sharma et al. 2005; Singh et al. 2007a; Singh et al.
2006).
These red-orange patches of Bodipy-D-erythro-LacCer
(appear yellow when red and green images are merged)
have the expected characteristics of PM microdomains. (1)
They are inhibited by treatment of cells with methyl--
cyclodextrin, which reduces the cholesterol content of cells
(Sharma et al. 2005). (2) These structures co-localize with
CTxB bound to cell surface GM1 ganglioside, demonstrating
that the microdomains are enriched in endogenous GSLs
(Fig. 5a). Bodipy-D-erythro-LacCer domains also co-local-
ize with PM 1-integrin (Sharma et al. 2005) as shown in
Fig. 4b. Since it is known that Bodipy-D-erythro-LacCer,
1-integrin, and CTxB (at least in part) are internalized via
caveolae, our results suggested that these microdomains
consist of lipids and proteins that are poised for endocytosis
via caveolae.
Bodipy-LacCer stereoisomers
We have also investigated the properties of the non-natural
stereoisomer Bodipy-L-threo-LacCer, which diVers from
Bodipy-D-erythro-LacCer by having a diVerent stereo-
chemical conWguration at only one carbon (C3 of the long-
chain base; see Fig 2b). Unlike the D-erythro stereoisomer,
Bodipy-L-threo-LacCer does not exhibit red-shifted PM
domains at higher concentrations (Fig. 4a, lower panels)
and does not co-localize with 1-integrin (Fig. 4b, lower
panels) at the PM. Interestingly, Bodipy-L-threo-LacCer
also is not internalized selectively by caveolae but instead
undergoes endocytosis by multiple routes (Singh et al.
2006). These studies suggest that Bodipy-L-threo-LacCer
does not concentrate in cholesterol and SL-enriched micro-
domains at the PM. Further studies have suggested a possi-
ble mechanism for the behavior of Bodipy-L-threo-LacCer.
First, the Xuorescence behavior of Bodipy-L-threo-LacCer
in liposomes was compared to that of the D-erythro analog.
Although Bodipy-D-erythro-LacCer in liposomes exhibits a
red shift at higher concentrations, this red shift is not seen
for the L-threo isomer in HSFs (Fig. 4c). A modeling study
of the structures for Bodipy-D-erythro and -L-threo-LacCer
suggested that in the L-threo stereoisomer the carbohydrate
head group and the Bodipy-fatty acid are likely to be
extended perpendicular from the sphingosine hydrocarbon
chain, while in the D-erythro form the head group extends
up and the Bodipy-fatty acid down in a more typical amphi-
pathic lipid orientation (Fig. 4d). These results suggest that
unlike the natural Bodipy-D-erythro-LacCer stereoisomer,
the LacCer analog with the L-threo stereochemistry may be
unable to associate closely with itself or with other GSLs,
leading to an inability to incorporate into cholesterol- and
SL-enriched domains. Additional studies with the other two
unnatural stereoisomers of Bodipy-LacCer (D-threo and L-
erythro) led to the conclusion that the stereochemistry at
carbon 3 (see Fig. 2b) of the long-chain base is a key deter-
minant for the inclusion of LacCer in SL/cholesterol-
enriched microdomains and for internalization via caveolae
(Singh et al. 2006).
Studies with the Xuorescent stereoisomers of LacCer
prompted us to compare the properties of D-erythro and L-
threo stereoisomers of a non-Xuorescent short-chain (octa-
noyl) analog of LacCer, C8-LacCer. We found that whereas
D-erythro-C8-LacCer induced the coalescence of microdo-
mains as detected by Bodipy-D-erythro-LacCer, CTxB,
BC-, and 1-integrin Fab staining, as well as stimulating
caveolar endocytosis (Sharma et al. 2005, Singh et al.
2007a),  L-threo-C8-LacCer inhibited the induction of826 Histochem Cell Biol (2008) 130:819–832
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microdomains by Simian Virus 40 binding or CTxB anti-
body cross-linking (Singh et al. 2007a). L-threo-C8-LacCer
also inhibited 1-integrin activation, Simian Virus 40 infec-
tion, and endocytosis via caveolae (Singh et al. 2007a).
Based on these studies and the above mentioned work with
Xuorescent analogs of LacCer, we suggest that the L-threo
stereoisomer of LacCer may perturb the formation of
microdomains by interfering with the close packing of
endogenous SLs.
Other Bodipy-SLs that label the PM
Our studies of other Bodipy-tagged SLs aside from LacCer
suggest that some of these lipid analogs may be useful for
Fig. 4 Comparison of D-erythro and L-threo stereoisomers of Bodipy-
LacCer. (a) Human skin Wbroblasts were incubated with the indicated
concentration of Bodipy-D-erythro (D-e) or L-threo- (L-t) LacCer for
30 min at 10°C, washed, and observed under the Xuorescence micro-
scope at low temperature to inhibit endocytosis. Images were acquired
simultaneously at green and red wavelengths, pseudocolored and dig-
itally merged. Note the presence of yellow/orange micron size patches
when Bodipy-D-erythro-LacCer was used at high concentrations. No
such domains were observed using Bodipy-L-threo-LacCer. b Map-
ping endocytic markers to PM domains. HSFs were co-incubated with
5 M Bodipy-D-erythro- or L-threo-LacCer and AF647-labeled anti-
1 integrin Fab. c Fluorescence emission spectra of small unilamellar
vesicles formed from POPC and containing 1, 2, 5, or 10 mol % Bo-
dipy-D-erythro-LacCer or -L-threo-LacCer. Note the presence of
monomer (515 nm) and excimer (620 nm) Xuorescence emission
peaks when the D-erythro isomer was used at high mol % fractions,
similar to Bodipy-Cer in Fig. 1b. In contrast, no excimer Xuorescence
was seen under the same conditions using the L-threo isomer. d Molec-
ular models of Bodipy-LacCer stereoisomers created using the
Chem3D program (Ultra 9.0, CambridgeSoft Corp., Cambridge, MA,
USa). All data are from (Singh et al. 2006), reproduced with permis-
sionHistochem Cell Biol (2008) 130:819–832 827
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the study of PM microdomains whereas others may not be
appropriate probes. In unpublished studies, we compared
the microdomains induced by Bodipy-D-erythro-GM3 gan-
glioside with those of Bodipy-D-erythro-LacCer. Although
areas of concentrated lipid analog as indicated by red Xuo-
rescence were visualized on the PM with Bodipy-D-
erythro-GM3, these structures did not co-localize with
CTxB (Fig. 5a, b) or 1-integrin (not shown). Thus,
Bodipy-D-erythro-GM3 appears to highlight microdomains
that are diVerent from those seen with Bodipy-D-erythro-
LacCer. This concept is consistent with previous observa-
tions that endogenous GM3 exists in diVerent microdo-
mains from domains enriched in GM1 ganglioside and
caveolin (Fujita et al. 2007; Iwabuchi et al. 1998; Janich
and Corbeil 2007).
Several Bodipy-SLs have been found to undergo
endocytosis by the same or similar mechanisms to Bodipy-
LacCer (e.g., via caveolae) in rat Wbroblasts (Singh et al.
2003). These lipids include Bodipy-derivatives of maltosyl
(Glc-Glc)-Cer, triosyl (Gal-Gal-Glc)-ceramide (globo-
side), sulfatide, and GM1 ganglioside (see Fig. 2a). While
these lipid analogs have not been investigated for their
ability to partition into microdomains on the PM, their
endocytosis via the same mechanism suggests that these
lipids may organize into similar domains prior to internal-
ization.
We have also investigated the internalization mechanism
of the Bodipy-SM stereoisomers. We found that Bodipy-D-
erythro-SM is internalized via a nystatin (inhibits endocy-
tosis via caveolae)-sensitive, chlorpromazine (inhibits
clathrin-dependent endocytosis)-insensitive mechanism in
human skin Wbroblasts, similar to the behavior of Bodipy-
D-erythro-LacCer. However, Bodipy-L-threo-SM endocy-
tosis is more sensitive to chlorpromazine, and is similar to
the results found with Bodipy-L-threo-LacCer (Singh et al.
2006). Thus, we speculate that the Bodipy-SM stereoiso-
mers will partition into PM domains similarly to their Lac-
Cer counterparts. However, some SM analogs are rapidly
hydrolyzed to Cer in several cell types, even at low temper-
ature (Koval and Pagano 1989, 1990). Thus, in microscopy
studies utilizing Xuorescent SM analogs, it is important to
analyze the metabolism of SM (e.g. by lipid extraction and
TLC) to ensure that the Xuorescence intensity reXects that
of SM and not of Cer or other metabolites (see below). A
possible solution to this problem would be to prepare a non-
hydrolyzable analog of SM; other such SLs have been syn-
thesized (Schwarzmann et al. 1995).
Finally, we have found that some Bodipy-SLs are inap-
propriate for studies of cell surface microdomains because
they are internalized via non-vesicular mechanisms (i.e.,
they “Xip” by active or passive transport). Bodipy-Cer with
the typical C18 long-chain base has been shown by us to be
internalized by cells even a low temperature (e.g., 10°C)
where endocytosis is not supported [see (Pagano et al.
1991) and Fig. 5b)]. In unpublished studies, we compared
the behavior of Bodipy-Cer with diVerent sphingosine
chain lengths (C12, C14, C16, C18, and C20). Of these, all
of the shorter chain length Bodipy-Cer analogs were inter-
nalized rapidly at low temperature; however, Bodipy-Cer
with a C20 long-chain base labeled the PM at 10°C
(Fig. 5b), suggesting that it could be used as a probe for
monitoring the formation of Cer-enriched microdomains at
the PM. Bodipy-GlcCer is also internalized at least in part
by a non-vesicular mechanism that does not require ATP
but appears to be saturable, suggesting transport by a “Xip-
pase” (Martin and Pagano 1994). Because of their ability to
enter the cell by non-endocytic processes Bodipy-Cer
(C18) and Bodipy-GlcCer in general are not useful for stud-
ies requiring prolonged labeling of the PM, particularly at
physiological temperatures.
Bodipy-cholesterol
Free cholesterol is thought to be transported through the
cell by multiple mechanisms including transbilayer
Fig. 5 Comparison of microdomains highlighted by Bodipy-LacCer
vs Bodipy-GM3 ganglioside. a) Co-localization of Bodipy-D-erythro-
LacCer and -GM3 with 1-integrin. Human skin Wbroblasts were incu-
bated 30 min at 10°C with 5 M Bodipy-lipid and AF647-Fab frag-
ment directed against 1-integrin. Bodipy-lipid was visualized by its
red emission and 1-integrin Fab using a far red Wlter. Note the co-
localization of Bodipy-LacCer but not GM3 with 1-integrin Fab. b
Comparison of human skin Wbroblast labeling with Bodipy-C18
(sphingosine)-Cer and C20(sphingosine)-Cer. Cells were incubated for
30 min at 10°C and then immediately imaged under the microscope at
10°C. Note the extensive PM labeling seen with the C20 analog and
greater labeling of the Golgi apparatus with the C18 Cer828 Histochem Cell Biol (2008) 130:819–832
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diVusion and active transport as well as within vesicular
structures (Fielding and Fielding 1997; Ikonen 2008;
Prinz  2002; Schroeder et al. 2001). When cells are
incubated with Bodipy-cholesterol, prominent PM
labeling is observed at short time points (2–5 min); how-
ever, upon longer incubations (¸30 min), Xuorescence
labeling of intracellular structures is also observed
(Hölttä-Vuori et al. 2008). Thus, the use Bodipy-choles-
terol for detection of PM microdomains remains to be
explored.
Labeling of microdomains on membranes 
of intracellular organelles
In addition to the occurrence of microdomains at the PM,
laterally segregated microdomains are thought to occur
on intracellular membranes. Indeed, early papers by
Simons and colleagues identiWed detergent-insoluble
complexes of lipids and proteins in Golgi-derived vesi-
cles destined for the apical membrane of MDCK cells
(Fiedler et al. 1993; Kurzchalia et al. 1992). These obser-
vations suggested that certain SL-enriched membrane
regions were segregated from others in the Golgi and
were critical in the development of the “lipid raft”
hypothesis. Microdomains are also expected to be found
on early and recycling endosomes. Both of these organ-
elles have been shown to be enriched in SLs and choles-
terol (Evans and Hardison 1985; Gagescu et al. 2000;
Hornick et al. 1997). Separate domains on early and
recycling endosomes also have been visualized using
Xuorescently tagged Rab proteins (Rabs 4, 5, and 11)
which can highlight distinct regions on the same endo-
some (Sonnichsen et al. 2000). Studies employing
immuno-electron microscopy have shown that some
internalized ligand-receptor complexes become sepa-
rated from each other in early endosomes, with ligands
(e.g., asialoglycoprotein, low-density lipoprotein) being
concentrated in the endosomal lumen and their receptors
enriched in tubular structures associated with the endo-
somes [(Geuze et al. 1983, 1987); see model in Fig. 6a].
Receptors in these tubules can recycle to the PM either
directly (rab4-dependent or “fast recycling”) or via pas-
sage through the recycling endosome (rab11-dependent
or “slow recycling”). The transferrin receptor (TfR) has a
somewhat unique itinerary in that after endocytosis and
delivery to the early endosome Tfr does not dissociate
from transferrin (Tfn) but rather both Tfn and TfR move
into tubules emanating from the early endosome. A por-
tion of the TfR/Tfn complex is then transported directly
back to the PM but most of the ligand/receptor complex
is transported to the recycling endosome and then
returned to the PM.
Visualization of endosomal microdomains 
with Bodipy-LacCer
After endocytosis via caveolae Bodipy-LacCer is trans-
ported through early endosomes (Sharma et al. 2003). By
allowing Bodipy-LacCer endocytosis (2.5 M) to occur for
1 h at 16°C, most of the endocytosed lipid is retained in the
early endosome (Sharma et al. 2003). Under these condi-
tions, Bodipy-LacCer can be seen in endosomes in the red
and green Xuorescence channels (Fig. 6b). In some cases,
both red and green Xuorescence is associated with the same
endosomal structure but segregated into diVerent regions of
the membrane, suggestive of microdomains [Fig. 6b;
(Sharma et al. 2003)]. When the same experiment is per-
formed with AlexaFluor 647-labeled Tfn (AF647-Tfn)
added together with Bodipy-LacCer, the AF647-Tfn (visu-
alized with a far red Wlter) is associated more closely with
the red (concentrated) Bodipy-LacCer regions than with the
green Bodipy-Xuorescence [Fig. 6c (Sharma et al. 2003)].
On warming to 37°C for 5 min, the AF647-Tfn and
Bodipy-red Xuorescence become separated from the green
Bodipy-LacCer  Xuorescence (Fig. 6d). Given the known
itinerary of Tfn through early endosomes, and then recy-
cling either directly or via recycling endosomes, these
results are interpreted as showing that a concentrated pool
of Bodipy-LacCer buds oV from the early endosome with
Tfn to be recycled to the PM (Sharma et al. 2003). We have
provided further evidence of Bodipy-LacCer recycling in
other studies (Choudhury et al. 2004). Other Bodipy-SLs
that are internalized by endocytosis (see above) are
expected to behave similarly but have not been examined
for their utility in visualizing endosomal microdomains.
Visualization of Golgi microdomains with Bodipy-LacCer
As mentioned above, the segregation of protein and lipid
cargo into microdomains at the Golgi membrane may be a
mechanism for the delivery of diVerent classes of materials
to diVerent destinations. For example, it has been proposed
that some proteins destined for delivery to apical mem-
branes of epithelial cells are segregated at the Golgi from
proteins that will be delivered to basolateral membranes
(Simons and van Meer 1988). In addition, just as there are
multiple types of budding from the PM for endocytosis
[e.g. clathrin-dependent vs clathrin-independent mecha-
nisms (Mayor and Pagano 2007)], there are multiple mech-
anisms by which vesicles or tubules are proposed to exit the
Golgi complex (Holthuis et al. 2001; Kepes et al. 2005).
Several Bodipy-SLs have been shown to become concen-
trated in the Golgi apparatus when added to multiple cell
types. These include Bodipy-Cer, -D-erythro-LacCer, -L-
threo-LacCer, -SM, and -GlcCer [unpublished observations
and (Chen et al. 1997; Choudhury et al. 2002b; Martin andHistochem Cell Biol (2008) 130:819–832 829
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Pagano 1994; Pagano et al. 1989; Puri et al. 2001; Sillence
et al. 2002)]. Bodipy-Cer has been shown to localize mainly
in the trans-Golgi and trans-Golgi network using electron
microscopy and a photoconversion method that is based on
the photobleaching of the Bodipy-Xuorophore in the presence
of diaminobenzidine (Ladinsky et al. 1994; Pagano et al.
1991). It is unknown if other Bodipy-SLs are incorporated
into the same Golgi compartment or other cisternae. When
viewed by Xuorescence microscopy, each of these Bodipy-
SLs can be seen at the Golgi apparatus at both green and red
wavelengths (e.g., Fig. 1d). With the advent of high resolu-
tion Xuorescence methods, it may be possible in the future to
detect SL domains at the Golgi using these analogs. One fea-
ture of Bodipy-Cer may be of further interest in this regard.
As Bodipy-Cer is rapidly metabolized (mainly to Bodipy-
SM) in the Golgi appparatus, it may be possible to load cells
with Bodipy-Cer, allow its conversion to SM in the Golgi
apparatus, and then view the budding of vesicles from the
Golgi which are enriched in Bodipy-SM. Early data from
(Pagano et al. 1991) suggests the feasibility of this approach.
Visualization of intracellular membrane microdomains 
with Bodipy-cholesterol
Few studies have been performed so far with Bodipy-cho-
lesterol; however, it has been shown that Bodipy-choles-
terol is rapidly concentrated in endosomes in CHO cells
(Hölttä-Vuori et al. 2008). In unpublished studies, we have
also observed that Bodipy-cholesterol is rapidly transported
to the intracellular structures in several other cell types
including rat oligodendrocytes. Thus, Bodipy-cholesterol
may be useful for visualizing cholesterol-enriched micro-
domains on intracellular membranes.
Future applications and perspectives
Although Bodipy-SLs have been used for cell biological
research for many years, their application to the study of
membrane microdomains has been recent. We have only
begun to learn about the characteristics of PM domains
Fig. 6 Use of Bodipy-lipids to label intracellular microdomains. a
Model of endosomal traYcking showing transport from the PM,
through early and recycling endosomes, followed by recycling back to
the PM. In some cases cargo or receptors may be transported from ear-
ly endosomes to late endosomes and lysosomes for degradation. b Hu-
man skin Wbroblasts were incubated with Bodipy-D-erythro-LacCer for
60 min at 16°C to load the early endosomal compartment. Cells then
were subject to back exchange to remove PM Xuorescence and imaged
at green and red wavelengths. Note that green and red Xuorescence
was sometimes found on distinct regions of individual endosomes. In
c, d human skin Wbroblasts were incubated with Bodipy-D-erythro-
LacCer and AF647-Tfn for 60 min at 16°C to load the early endosomal
compartment as in panel (a). Cells were then subjected to back
exchange and acid stripping to remove PM Xuorescence. Cells were
then incubated at 37°C for c 0 or d 5 min, and photographed at green
and red wavelengths (for low and high concentrations of Bodipy) and
at far red wavelengths for Tfn. Images were rendered in pseudocolor
with green and red corresponding to LacCer microdomains and blue
corresponding to Tfn Xuorescence. Note the close correspondence of
red and blue in (c), indicating the presence of high concentrations of
Bodipy-LacCer and Tfn in the same domains of endosomes. Upon
warming to 37°C (panel d), the concentrated (red) pool of Bodipy-Lac-
Cer and Tfn become separated from the lower concentration (green)
pool of Bodipy-LacCer, en route to recycling back to the PM. Panels
(b–d) are reproduced from (Sharma et al. 2003), with permission830 Histochem Cell Biol (2008) 130:819–832
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highlighted by Bodipy-LacCer and how they are regulated.
Our preliminary studies showing that Bodipy-GM3 is
localized in diVerent microdomains at the PM suggest the
possibility that other Bodipy-derivatives of GSLs [e.g., GD
or GT series gangliosides; for a review, see (Kolter et al.
2002)] may partition into distinct membrane domains. The
labeling of intracellular organelles with Bodipy-cholesterol
suggests the potential for using this lipid probe to investi-
gate intracellular microdomains and the rapid transport of
cholesterol into and out of these microdomains.
Thus far our studies of PM microdomains have relied on
the use of low temperature (4–10°C) to prevent endocytosis
of Bodipy-SLs and thus allow the visualization of the lipid
probes exclusively at the PM. It will be important to study
the behavior of Bodipy-SL-labeled microdomains at physio-
logical temperature (37°C) to determine if they are similar
to those seen at low temperature and to study their dynam-
ics and stability. This kind of experiment may be executed
by inhibiting the endocytosis of the lipid probe [e.g., for
Bodipy-LacCer with a src kinase inhibitor or a dominant
negative dynamin (Cheng et al. 2006; Puri et al. 2001;
Sharma et al. 2004; Singh et al. 2003)].
Studies need to be performed to determine if some of the
Bodipy-related Xuorophores (e.g., Bodipy-TR) will be as
useful as Bodipy-FL for labeling lipid probes. For example,
would Bodipy-TR-SL readily transfer to cells from a BSA
complex, would the Bodipy-TR fatty acid moiety associate
with the PM, and would such probes faithfully mimic natu-
ral SLs (e.g., are they metabolized and/or transported to the
Golgi apparatus)? Probes with red-shifted Xuorescence
would be very useful for co-localization with green Xuores-
cent proteins, an approach that is not usually feasible with
Bodipy-FL probes because their Xuorescence overlaps with
green Xuorescent proteins. Another potential solution to the
problem of Bodipy-FL Xuorescence overlap with Xuores-
cent proteins is the use of far-red shifted Xuorescent protein
tags, which are now commercially available. The ability to
simultaneously visualize both a Xuorescent SL and a micro-
domain-associated protein (e.g., Cav1/far red Xuorescent
protein) at the PM could provide new information about the
coalescence of microdomains in the moments before endo-
cytosis.
Finally, most of the Bodipy-SLs that have been dis-
cussed label the outer leaXet of the PM. Little information
is available about the lipid composition or microdomain
organization on the inner leaXet “beneath” the outer leaXet
microdomains. The possibility of mapping outer leaXet
Bodipy-SL microdomains to inner leaXet regions enriched
in various phosphoinositides through the use of phosphati-
dylinositol-sensing domains or Xuorescent proteins that tar-
get to inner leaXet microdomains (Abankwa et al. 2007;
Lasserre et al. 2008) could provide new advances in our
understanding of transbilayer coupling.
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